CN108208853A - 一种解酒护肝益生菌低聚肽复合制剂及制备方法 - Google Patents
一种解酒护肝益生菌低聚肽复合制剂及制备方法 Download PDFInfo
- Publication number
- CN108208853A CN108208853A CN201810007826.9A CN201810007826A CN108208853A CN 108208853 A CN108208853 A CN 108208853A CN 201810007826 A CN201810007826 A CN 201810007826A CN 108208853 A CN108208853 A CN 108208853A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- blcc2
- probiotics
- culture
- compound formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 115
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 115
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 210000004185 liver Anatomy 0.000 title claims abstract description 65
- 108010038807 Oligopeptides Proteins 0.000 title claims abstract description 62
- 102000015636 Oligopeptides Human genes 0.000 title claims abstract description 62
- 238000009472 formulation Methods 0.000 title claims abstract description 52
- 150000001875 compounds Chemical class 0.000 title claims abstract description 51
- 230000002633 protecting effect Effects 0.000 title claims abstract description 36
- 208000007848 Alcoholism Diseases 0.000 title claims abstract description 33
- 201000007930 alcohol dependence Diseases 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 94
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 94
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 94
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 85
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 85
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 82
- 241000894006 Bacteria Species 0.000 claims abstract description 68
- 240000008042 Zea mays Species 0.000 claims abstract description 37
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 37
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 30
- 235000009973 maize Nutrition 0.000 claims abstract description 30
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 28
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 28
- 239000000470 constituent Substances 0.000 claims abstract description 12
- 230000000529 probiotic effect Effects 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 49
- 238000000855 fermentation Methods 0.000 claims description 39
- 230000004151 fermentation Effects 0.000 claims description 39
- 239000002609 medium Substances 0.000 claims description 37
- 241000186660 Lactobacillus Species 0.000 claims description 25
- 229940039696 lactobacillus Drugs 0.000 claims description 25
- 238000004108 freeze drying Methods 0.000 claims description 20
- 229920001817 Agar Polymers 0.000 claims description 19
- 239000008272 agar Substances 0.000 claims description 19
- 238000011218 seed culture Methods 0.000 claims description 19
- 241001608472 Bifidobacterium longum Species 0.000 claims description 18
- 230000004913 activation Effects 0.000 claims description 18
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 16
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 16
- 239000012530 fluid Substances 0.000 claims description 16
- 241000186000 Bifidobacterium Species 0.000 claims description 15
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 15
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 15
- 244000199866 Lactobacillus casei Species 0.000 claims description 15
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 15
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 15
- 229940017800 lactobacillus casei Drugs 0.000 claims description 15
- 239000004615 ingredient Substances 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 10
- 235000015278 beef Nutrition 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 10
- 239000000306 component Substances 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 239000002054 inoculum Substances 0.000 claims description 8
- 239000003223 protective agent Substances 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 7
- 235000005822 corn Nutrition 0.000 claims description 7
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 7
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 7
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 7
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 7
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 7
- 210000000481 breast Anatomy 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 claims description 5
- 230000008901 benefit Effects 0.000 claims description 5
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 5
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 5
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- 108010009004 proteose-peptone Proteins 0.000 claims description 5
- 235000020183 skimmed milk Nutrition 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 241001052560 Thallis Species 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 4
- 230000010355 oscillation Effects 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 239000012531 culture fluid Substances 0.000 claims description 3
- 239000012533 medium component Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 18
- 239000003814 drug Substances 0.000 abstract description 12
- 108010021809 Alcohol dehydrogenase Proteins 0.000 abstract description 6
- 102000007698 Alcohol dehydrogenase Human genes 0.000 abstract description 5
- 150000001413 amino acids Chemical class 0.000 abstract description 4
- 230000002503 metabolic effect Effects 0.000 abstract description 4
- 238000009825 accumulation Methods 0.000 abstract description 3
- 239000013022 formulation composition Substances 0.000 abstract description 2
- 235000019441 ethanol Nutrition 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 230000006378 damage Effects 0.000 description 13
- 210000005229 liver cell Anatomy 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 231100000753 hepatic injury Toxicity 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 235000013406 prebiotics Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 4
- 206010067125 Liver injury Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 208000002353 alcoholic hepatitis Diseases 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003833 bile salt Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 230000015784 hyperosmotic salinity response Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 2
- 241000825107 Hierochloe Species 0.000 description 2
- 235000015466 Hierochloe odorata Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 206010070545 Bacterial translocation Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- BFVQTKQTUCQRPI-YYEZTRBPSA-N LPS with O-antigen Chemical compound O([C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]5[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O5)O)O4)O)[C@@H](O)[C@@H](CO)O3)NC(C)=O)[C@@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)NC(C)=O)O2)NC(C)=O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)OC([C@@H]1O)O[C@H]1[C@H](O)[C@@H]([C@@H](O)COC2[C@H]([C@@H](O)[C@H](OP(O)(O)=O)[C@@H]([C@@H](O)CO)O2)O)OC([C@H]1O)O[C@H]1[C@H](OP(O)(=O)OP(O)(=O)OCCN)[C@@H]([C@@H](O)CO)OC([C@H]1O)O[C@H]1[C@H](O[C@]2(O[C@@H]([C@@H](O)[C@H](O[C@]3(O[C@@H]([C@@H](O)[C@H](OP(O)(=O)OCCN)C3)[C@@H](O)CO)C(O)=O)C2)[C@@H](O)CO)C(O)=O)C[C@](O[C@@H]1[C@@H](O)CO)(OC[C@H]1O[C@@H](OC[C@@H]2[C@H]([C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O2)O)[C@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@H]([C@@H]1OP(O)(O)=O)OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O BFVQTKQTUCQRPI-YYEZTRBPSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- -1 alanine and leucine Chemical class 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000007375 bacterial translocation Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810007826.9A CN108208853B (zh) | 2018-01-04 | 2018-01-04 | 一种解酒护肝益生菌低聚肽复合制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810007826.9A CN108208853B (zh) | 2018-01-04 | 2018-01-04 | 一种解酒护肝益生菌低聚肽复合制剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108208853A true CN108208853A (zh) | 2018-06-29 |
CN108208853B CN108208853B (zh) | 2021-03-26 |
Family
ID=62645262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810007826.9A Active CN108208853B (zh) | 2018-01-04 | 2018-01-04 | 一种解酒护肝益生菌低聚肽复合制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108208853B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109350629A (zh) * | 2018-08-09 | 2019-02-19 | 新乡医学院 | 一种用于治疗酒精戒断综合征的益生菌复合制剂及其制备方法 |
CN109662322A (zh) * | 2019-02-02 | 2019-04-23 | 福建晋江国食文化传媒有限公司 | 一种保肝护心血管的组合物及其制备方法 |
CN111000101A (zh) * | 2019-11-14 | 2020-04-14 | 南方医科大学 | 一种具有高效解酒护肝的组合物及包含其的饮品 |
CN111249371A (zh) * | 2018-11-30 | 2020-06-09 | 内蒙古伊利实业集团股份有限公司 | 解酒护肝组合物及产品 |
CN111548947A (zh) * | 2019-06-06 | 2020-08-18 | 郑州大学 | 乳酸菌产品及其解酒用途 |
CN112137112A (zh) * | 2020-09-21 | 2020-12-29 | 杭州迈亚塔生物科技有限公司 | 一种解酒护肝复合食品及其制备方法 |
CN112438358A (zh) * | 2020-11-17 | 2021-03-05 | 上海昊岳食品科技有限公司 | 护肝益生菌固体饮料及其制备方法 |
CN113475663A (zh) * | 2021-07-21 | 2021-10-08 | 吉林大学 | 一种含肽益生菌组合物、含肽益生菌固体饮料及其制备方法 |
CN114010665A (zh) * | 2021-11-30 | 2022-02-08 | 西南医科大学附属医院 | 罗伊氏乳杆菌在制备预防和/或治疗酒精性肝病的药物中的应用 |
CN114468046A (zh) * | 2020-11-13 | 2022-05-13 | 江苏万邦医药科技有限公司 | 一种具有解酒保肝护胃功效的组合物 |
CN114522218A (zh) * | 2022-03-14 | 2022-05-24 | 唐建 | 一种快速解酒护肝保肝的组合物及其制备方法 |
CN115005437A (zh) * | 2022-05-31 | 2022-09-06 | 仁和全域(上海)大健康研究院有限公司 | 一种具有解酒护肝功效的酵素饮料及其制备方法 |
CN116236510A (zh) * | 2023-03-07 | 2023-06-09 | 微康益生菌(苏州)股份有限公司 | 一种改善慢性酒精诱导的肝疾病的益生菌剂及其应用 |
CN116473239A (zh) * | 2023-04-17 | 2023-07-25 | 江苏恰瑞生物科技有限公司 | 一种缓解急性酒精性肝损伤的蛋白肽组合物及其制备方法 |
CN116508991A (zh) * | 2023-05-17 | 2023-08-01 | 哈尔滨三联药业股份有限公司 | 解酒组合物及其制备方法和应用 |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102132869A (zh) * | 2011-02-18 | 2011-07-27 | 陕西师范大学 | 一种具解酒防醉作用保健用品的制备 |
CN104068388A (zh) * | 2014-01-14 | 2014-10-01 | 胡安然 | 一种调理肝肿瘤的膳食 |
CN104845903A (zh) * | 2015-02-13 | 2015-08-19 | 山东凤凰生物有限公司 | 嗜甘草的植物乳杆菌及其制备的甘草益生菌制剂 |
CN104988104A (zh) * | 2015-08-13 | 2015-10-21 | 山东凤凰生物有限公司 | 一株具有吸附或降解肠毒素功能的乳酸菌及其应用 |
CN105018379A (zh) * | 2015-07-16 | 2015-11-04 | 山东凤凰生物有限公司 | 一株具高抗氧化活性的植物乳杆菌及其应用 |
CN105039217A (zh) * | 2015-07-16 | 2015-11-11 | 山东凤凰生物有限公司 | 一种降血糖益生菌制剂及其制备方法 |
CN105079450A (zh) * | 2015-08-06 | 2015-11-25 | 山东凤凰生物有限公司 | 缓解老年人阴虚型便秘的益生菌中药制剂及其制备方法和应用 |
CN105288170A (zh) * | 2015-12-08 | 2016-02-03 | 济南舜祥医药科技有限公司 | 一种解酒护肝伴饮 |
CN106266105A (zh) * | 2016-09-05 | 2017-01-04 | 三株福尔制药有限公司 | 一种解酒保肝的益生菌发酵中药组合物及其制备方法和应用 |
CN106420847A (zh) * | 2016-06-30 | 2017-02-22 | 山东凤凰生物有限公司 | 辅助保护胃黏膜和/或缓解胃胀的组合物及其微生态制剂 |
CN106578773A (zh) * | 2017-02-14 | 2017-04-26 | 西华大学 | 一种新型解酒饮料及其制备方法 |
CN106666703A (zh) * | 2016-07-11 | 2017-05-17 | 佛山市朗达信息科技有限公司 | 具有保肝护肝功效的酵素组合物、制剂及制备方法 |
CN106858577A (zh) * | 2017-04-11 | 2017-06-20 | 姜红成 | 制备具有保肝护肝、调节脂肪肝代谢功能的植物酵素的发酵组合物及制法 |
CN107095113A (zh) * | 2017-05-23 | 2017-08-29 | 安徽元麦凡康食品有限公司 | 一种解酒护肝固体饮料 |
CN107149068A (zh) * | 2017-05-10 | 2017-09-12 | 重庆市春旭农业发展有限公司 | 一种蜂蜜醒酒饮料及其制备方法 |
-
2018
- 2018-01-04 CN CN201810007826.9A patent/CN108208853B/zh active Active
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102132869A (zh) * | 2011-02-18 | 2011-07-27 | 陕西师范大学 | 一种具解酒防醉作用保健用品的制备 |
CN104068388A (zh) * | 2014-01-14 | 2014-10-01 | 胡安然 | 一种调理肝肿瘤的膳食 |
CN104845903A (zh) * | 2015-02-13 | 2015-08-19 | 山东凤凰生物有限公司 | 嗜甘草的植物乳杆菌及其制备的甘草益生菌制剂 |
CN105018379A (zh) * | 2015-07-16 | 2015-11-04 | 山东凤凰生物有限公司 | 一株具高抗氧化活性的植物乳杆菌及其应用 |
CN105039217A (zh) * | 2015-07-16 | 2015-11-11 | 山东凤凰生物有限公司 | 一种降血糖益生菌制剂及其制备方法 |
CN105079450A (zh) * | 2015-08-06 | 2015-11-25 | 山东凤凰生物有限公司 | 缓解老年人阴虚型便秘的益生菌中药制剂及其制备方法和应用 |
CN104988104A (zh) * | 2015-08-13 | 2015-10-21 | 山东凤凰生物有限公司 | 一株具有吸附或降解肠毒素功能的乳酸菌及其应用 |
CN105288170A (zh) * | 2015-12-08 | 2016-02-03 | 济南舜祥医药科技有限公司 | 一种解酒护肝伴饮 |
CN106420847A (zh) * | 2016-06-30 | 2017-02-22 | 山东凤凰生物有限公司 | 辅助保护胃黏膜和/或缓解胃胀的组合物及其微生态制剂 |
CN106666703A (zh) * | 2016-07-11 | 2017-05-17 | 佛山市朗达信息科技有限公司 | 具有保肝护肝功效的酵素组合物、制剂及制备方法 |
CN106266105A (zh) * | 2016-09-05 | 2017-01-04 | 三株福尔制药有限公司 | 一种解酒保肝的益生菌发酵中药组合物及其制备方法和应用 |
CN106578773A (zh) * | 2017-02-14 | 2017-04-26 | 西华大学 | 一种新型解酒饮料及其制备方法 |
CN106858577A (zh) * | 2017-04-11 | 2017-06-20 | 姜红成 | 制备具有保肝护肝、调节脂肪肝代谢功能的植物酵素的发酵组合物及制法 |
CN107149068A (zh) * | 2017-05-10 | 2017-09-12 | 重庆市春旭农业发展有限公司 | 一种蜂蜜醒酒饮料及其制备方法 |
CN107095113A (zh) * | 2017-05-23 | 2017-08-29 | 安徽元麦凡康食品有限公司 | 一种解酒护肝固体饮料 |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109350629A (zh) * | 2018-08-09 | 2019-02-19 | 新乡医学院 | 一种用于治疗酒精戒断综合征的益生菌复合制剂及其制备方法 |
CN111249371A (zh) * | 2018-11-30 | 2020-06-09 | 内蒙古伊利实业集团股份有限公司 | 解酒护肝组合物及产品 |
CN109662322A (zh) * | 2019-02-02 | 2019-04-23 | 福建晋江国食文化传媒有限公司 | 一种保肝护心血管的组合物及其制备方法 |
CN111548947A (zh) * | 2019-06-06 | 2020-08-18 | 郑州大学 | 乳酸菌产品及其解酒用途 |
CN111000101B (zh) * | 2019-11-14 | 2021-08-13 | 南方医科大学 | 一种具有高效解酒护肝的组合物及包含其的饮品 |
CN111000101A (zh) * | 2019-11-14 | 2020-04-14 | 南方医科大学 | 一种具有高效解酒护肝的组合物及包含其的饮品 |
CN112137112A (zh) * | 2020-09-21 | 2020-12-29 | 杭州迈亚塔生物科技有限公司 | 一种解酒护肝复合食品及其制备方法 |
CN114468046A (zh) * | 2020-11-13 | 2022-05-13 | 江苏万邦医药科技有限公司 | 一种具有解酒保肝护胃功效的组合物 |
CN112438358A (zh) * | 2020-11-17 | 2021-03-05 | 上海昊岳食品科技有限公司 | 护肝益生菌固体饮料及其制备方法 |
CN113475663A (zh) * | 2021-07-21 | 2021-10-08 | 吉林大学 | 一种含肽益生菌组合物、含肽益生菌固体饮料及其制备方法 |
CN114010665A (zh) * | 2021-11-30 | 2022-02-08 | 西南医科大学附属医院 | 罗伊氏乳杆菌在制备预防和/或治疗酒精性肝病的药物中的应用 |
CN114522218A (zh) * | 2022-03-14 | 2022-05-24 | 唐建 | 一种快速解酒护肝保肝的组合物及其制备方法 |
CN114522218B (zh) * | 2022-03-14 | 2022-11-18 | 唐建 | 一种快速解酒护肝保肝的组合物及其制备方法 |
CN115005437B (zh) * | 2022-05-31 | 2024-04-26 | 仁和全域(上海)大健康研究院有限公司 | 一种具有解酒护肝功效的酵素饮料及其制备方法 |
CN115005437A (zh) * | 2022-05-31 | 2022-09-06 | 仁和全域(上海)大健康研究院有限公司 | 一种具有解酒护肝功效的酵素饮料及其制备方法 |
CN116236510A (zh) * | 2023-03-07 | 2023-06-09 | 微康益生菌(苏州)股份有限公司 | 一种改善慢性酒精诱导的肝疾病的益生菌剂及其应用 |
CN116236510B (zh) * | 2023-03-07 | 2023-12-19 | 微康益生菌(苏州)股份有限公司 | 一种改善慢性酒精诱导的肝疾病的益生菌剂及其应用 |
CN116473239B (zh) * | 2023-04-17 | 2023-11-21 | 江苏恰瑞生物科技有限公司 | 一种缓解急性酒精性肝损伤的蛋白肽组合物及其制备方法 |
CN116473239A (zh) * | 2023-04-17 | 2023-07-25 | 江苏恰瑞生物科技有限公司 | 一种缓解急性酒精性肝损伤的蛋白肽组合物及其制备方法 |
CN116508991A (zh) * | 2023-05-17 | 2023-08-01 | 哈尔滨三联药业股份有限公司 | 解酒组合物及其制备方法和应用 |
CN116508991B (zh) * | 2023-05-17 | 2023-11-24 | 哈尔滨三联药业股份有限公司 | 解酒组合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN108208853B (zh) | 2021-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108208853A (zh) | 一种解酒护肝益生菌低聚肽复合制剂及制备方法 | |
CN104509864B (zh) | 一种具有改善胃肠功能的营养保健食品及其制备方法 | |
CN105146614B (zh) | 一种功能性钙果酵素、酵素饮料及其生产方法 | |
CN105167072B (zh) | 一种功能性枸杞酵素及其制品的生产方法 | |
US20140363501A1 (en) | The protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury | |
US9649347B2 (en) | Protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury | |
CN102174450B (zh) | 一种抗幽门螺杆菌感染的植物乳杆菌及其用途 | |
WO2013127146A1 (zh) | 一种能够缓解铅毒性的植物乳杆菌及其用途 | |
CN1911118B (zh) | 一种开菲尔冻干菌粉及其制备方法和应用 | |
CN112056399A (zh) | 一种增强免疫力的益生菌组合物及其应用 | |
CN109929779A (zh) | 一种含有生物活性肽的益生菌制剂及其制备方法和应用 | |
CN109628358A (zh) | 一种复合益生菌及其应用 | |
WO2014032375A1 (zh) | 一种具有排镉功能的植物乳杆菌及其用途 | |
CN105641209A (zh) | 具有提高免疫力功能的益生菌组合物及其制备方法与应用 | |
CN108913639A (zh) | 一种鼠李糖乳杆菌复合剂及其制备方法和应用 | |
CN108782758A (zh) | 一种发酵型合生元羊奶粉及其制备方法 | |
CN108913638A (zh) | 一种嗜酸乳杆菌复合剂及其制备方法和应用 | |
CN108913637A (zh) | 一种植物乳杆菌复合剂及其制备方法和应用 | |
CN106858577A (zh) | 制备具有保肝护肝、调节脂肪肝代谢功能的植物酵素的发酵组合物及制法 | |
CN113337435A (zh) | 益生菌组合物及其在食品中的应用 | |
CN109528814A (zh) | 一种乳酸菌发酵黄芪的微生态制剂及其制备方法和应用 | |
CN108795823B (zh) | 一种改善女性孕产妇肠道菌群的益生菌的培养方法和应用 | |
CN105802876B (zh) | 一种复合益生菌发酵苜蓿嫩芽粉制剂及其制备方法和应用 | |
CN103571767A (zh) | 利用食用琼脂的双重涂布乳酸菌粉及其制备方法 | |
CN109527099A (zh) | 一种枸杞复合益生菌羊奶片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 271099 No. 17 Huayuan Road, Taishan District, Tai'an City, Shandong Province Patentee after: Shandong Fenghuang Biotechnology Co.,Ltd. Address before: 271000 Fengtai Village, Shanggao office, Taishan District, Tai'an City, Shandong Province Patentee before: SHANDONG PHOENIX BIO-TECH. Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A probiotic oligopeptide composite preparation and preparation method for sobering up and protecting the liver Effective date of registration: 20231227 Granted publication date: 20210326 Pledgee: Taian Bank Co.,Ltd. Daizong sub branch Pledgor: Shandong Fenghuang Biotechnology Co.,Ltd. Registration number: Y2023980074803 |